Celularity Inc. Class A Common Stock
CELU Real Time Price USDRecent trades of CELU by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CELU's directors and management
Government lobbying spending instances
-
$10,000 Jul 18, 2023 Issue: Health Issues
-
$10,000 Jan 17, 2023 Issue: Health Issues
-
$10,000 Oct 19, 2022 Issue: Health Issues
-
$10,000 Jul 19, 2022 Issue: Health Issues
-
$10,000 Apr 19, 2022 Issue: Health Issues
-
$10,000 Jan 19, 2022 Issue: Health Issues
-
$10,000 Oct 19, 2021 Issue: Health Issues
-
$10,000 Jul 19, 2021 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Use of placental stem cells in treatment of acute kidney injury Jul. 11, 2023
-
Patent Title: Enhanced placental stem cells and uses thereof Nov. 29, 2022
-
Patent Title: Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells Nov. 23, 2021
-
Patent Title: Placenta-derived adherent cell exosomes and uses thereof Nov. 16, 2021
-
Patent Title: Treatment of pain using placental stem cells Aug. 17, 2021
-
Patent Title: Composition for collecting and preserving placental stem cells and methods of using the composition Mar. 17, 2020
-
Patent Title: Methods for quantifying particulates in cell culture Feb. 18, 2020
-
Patent Title: Methods for collecting and using placenta cord blood stem cells Feb. 04, 2020
-
Patent Title: Cd34 Dec. 03, 2019
-
Patent Title: Placental stem cell populations Aug. 20, 2019
-
Patent Title: Enhanced placental stem cells and uses thereof Jun. 25, 2019
-
Patent Title: Therapy with cells from human placenta and hematopoietic cells Jan. 15, 2019
-
Patent Title: Method of collecting placental stem cells Oct. 30, 2018
-
Patent Title: Methods and compositions for treatment of bone defects with placental cell populations Oct. 23, 2018
-
Patent Title: Cell composition and methods of making the same Oct. 23, 2018
-
Patent Title: Method of producing erythrocytes without feeder cells Aug. 07, 2018
-
Patent Title: Human placental collagen compositions, and methods of making and using the same May. 22, 2018
-
Patent Title: Treatment of amyotrophic lateral sclerosis using placental stem cells Mar. 27, 2018
-
Patent Title: Human placental collagen compositions, and methods of making and using the same Oct. 03, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CELU in WallStreetBets Daily Discussion
Recent insights relating to CELU
Recent picks made for CELU stock on CNBC
ETFs with the largest estimated holdings in CELU
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CELU Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.